Skip to content

Repligen RGEN Q2 2024 earnings

Reported July 30, 2024 · Before market open

Revenue$154.1MIn line
EPS$0.33In line
Revenue estimate$154.1M
EPS estimate$0.33

Next report

Oct 27, 2026 (in 3 months)
Revenue estimate$206.9M
EPS estimate$0.46

Financials

Q2 2024

Income statement

See full
Revenue$154.1M-3.2%
Gross profit$76.8M-3.9%
Operating income$1.5M-92.3%
Net income$3.3M-83.4%
EPS (diluted)$0.06-82.9%

Balance sheet

See full
Cash & equivalents$809.1M+34.0%
Total debt$155.6M+13.3%
Total equity$2.0B+0.7%
Total assets$2.9B+12.3%

Cash flow

See full
Operating cash flow$42.2M+22.4%
CapEx$4.8M-41.7%
Free cash flow$37.4M+42.5%

Valuation & ratios

Valuation

as of 06/30/24
See full
Market cap$7.03B-10.8%
Enterprise value$6.38B-14.0%
P/S11.8×+1.0×

Profitability

See full
Gross margin41.9%-11.7pp
FCF margin20.6%+6.9pp

Returns & leverage

See full
Debt / equity0.1×0.0×
Current ratio6.6×+4.0×

Segments

By product

See full
Proteins Products$18.6M
Process Analytics Products$14.8M
Royalty$35.0K-2.8%

Versus estimates

Ask the moment Repligen reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Repligen report Q2 2024 earnings?
Repligen (RGEN) reported Q2 2024 earnings on July 30, 2024 before market open.
What were Repligen's Q2 2024 revenue and EPS?
Repligen reported revenue of $154.1M and eps of $0.33 for Q2 2024.
Did Repligen beat estimates in Q2 2024?
Revenue missed the consensus estimate of $154.1M by $47.0K. EPS beat the consensus estimate of $0.33 by $0.00.
Where can I find Repligen's Q2 2024 SEC filings?
You can read the 10-Q periodic report (0000950170-24-087981) directly on SEC EDGAR. The filing index links above go to sec.gov.